Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jian Pi Jie Yu Gao is a Traditional Chinese Medicine (TCM) herbal paste formulation primarily indicated for the treatment of depressive disorders, particularly those categorized under the TCM pattern of Spleen deficiency and Liver Qi stagnation. The formulation is designed to strengthen the Spleen, regulate Qi, and resolve emotional depression. It is frequently utilized as a hospital preparation in China, most notably by the Affiliated Hospital of Shandong University of Traditional Chinese Medicine, for conditions such as post-stroke depression and functional dyspepsia with comorbid mood symptoms. The preparation involves the decoction and concentration of multiple botanical ingredients—typically including *Astragalus membranaceus*, *Atractylodes macrocephala*, and *Bupleurum chinense*—into a semi-solid oral paste. Clinical research suggests the formula may exert antidepressant effects by modulating the gut-brain axis, increasing monoamine neurotransmitter levels, and upregulating brain-derived neurotrophic factor (BDNF) expression.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jian Pi Jie Yu Gao.